跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 195 条关于
“Pearl”
全部
195
临床试验
127
药物
7
机构
10
资讯
51
去年
PEARL Study: Durvalumab Monotherapy Shows Promise in NSCLC Patients with High PD-L1 Expression
去年
Pearl Achieves Historic FDA Clearance for First AI Platform Supporting Both 2D and 3D Dental Imaging Analysis
8个月前
Galderma Presents Phase 3 Data on Relfydess Neuromodulator at TOXINS 2026, Demonstrating Superior Efficacy and Duration
去年
CDK4/6 Inhibitors Maintain Key Role in ER+/HER2- Breast Cancer Treatment Strategies
去年
Galderma's Relfydess Shows Rapid, Long-Lasting Improvement for Frown Lines in Phase IIIb Trial
去年
Fremanezumab Demonstrates Long-Term Efficacy in Migraine Prevention Across Multiple Real-World Studies
9个月前
AJOVY Becomes First CGRP Antagonist Approved for Pediatric Migraine Prevention Following Positive SPACE Trial Results
5天前
FDA Accepts Organon's sNDA to Extend Hormone-Free IUD MIUDELLA to Six Years of Use
去年
Pipeline Analysis Reveals 20+ Drug Candidates for c-MET+ NSCLC Treatment
去年
Neurogen Biomarking to Present Validation Data for At-Home Alzheimer's Blood Biomarker Test at AAIC 2025
第 1 页,共 6 页
上一页
下一页